CanSense’s test is a blood-based assay that uses laser spectroscopy and artificial intelligence to identify early-stage colorectal cancer and precancerous polyps.
Keep Reading
Add A Comment
Trending
- GI Grand Rounds lecture – GI 2.0: From Procedures to Pathways
- Gastroenterology Practice Economics: Benchmark 2026 (Jiro Health)
- Surgery Partners to be taken private by Bon Secours affiliate in $5.7 billion deal (Reuters)
- Guardant Health Applauds New Law Ensuring Access to Colorectal Cancer Screening Innovations with No Cost-Sharing for Pennsylvanians (Guardant Health)
- Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer (Genmab)
- Do Wearables in GI Care Provide Useful Data or Fuel Anxiety? (Medscape)
- APPs Poised to Level the Playing Field for Rural Patients With IBD (GI & Endoscopy News)
- Improve IBD bowel checks for early cancer detection, study finds (Eurekalert)
